Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PH94B in Adjustment Disorder with Anxiety
NCT04404192Phase 2Completed
- Sponsor
- Vistagen Therapeutics
- Start
- Oct 2021
- Primary completion
- Dec 2022
- Countries
- 1
01
Overview
A Phase 2 trial of fasedienol in adjustment disorder with anxious mood, sponsored by Vistagen Therapeutics. Started Oct 2021; status: completed.
02
Drugs
fasedienol
03
Conditions
adjustment disorder with anxious mood
Beyond the preview
Go deeper on NCT04404192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04404192.